This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

hsTnT After Elective Coronary Angiography

This study has been completed.
Information provided by (Responsible Party):
Haitham Abu Sharar, University Hospital Heidelberg Identifier:
First received: November 24, 2012
Last updated: December 6, 2014
Last verified: December 2014
A prospective Study, aiming to understand and analyse the key role of the novel High Sensitivity Troponin T (hsTnT) within a group of patients undergoing an uncomplicated coronary angiography without receiving any additional intervention. The peri-procedural elevation of the hsTnT indicates some other factors being responsible for the elevation of the hsTnT in absence of an acute coronary syndrome, such as physiological components or micro-injuries. A one year follow-up has been collected.

Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Rise of hscTnT After Elective Coronary Angiography Without Coronary Intervention

Further study details as provided by Haitham Abu Sharar, University Hospital Heidelberg:

Primary Outcome Measures:
  • Cardiovascular mortality [ Time Frame: Up to 12 months after procedure ]

Enrollment: 545
Study Start Date: February 2010
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
CAG without PCI
CAG with PCI


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Consecutive patients with stable or unknown CAD undergoing CAG with/or without PCI. Patients receiving additional examination, such as biopsy, Ablation or any other procedure that could lead to myocardial injury resulting in elevation of the cardiac Troponin are being excluded, as well as Patients with acute coronary syndrome.

Inclusion Criteria:

- Stable or unknown CAD

Exclusion Criteria:

- Acute Coronary Syndrome

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01735500

Department of Cardiology - University Hospital of Heidelberg
Heidelberg, Germany, 69120
Sponsors and Collaborators
University Hospital Heidelberg
Principal Investigator: Evangelos Giannitsis, Prof. Dr. med. Department of Cardiology, University Hospital of Heidelberg
  More Information

Responsible Party: Haitham Abu Sharar, Dr. med., University Hospital Heidelberg Identifier: NCT01735500     History of Changes
Other Study ID Numbers: hsTnT Elective CAG
Study First Received: November 24, 2012
Last Updated: December 6, 2014

Keywords provided by Haitham Abu Sharar, University Hospital Heidelberg:
cardia Troponin T
in stable

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases processed this record on August 18, 2017